Rhabdoid tumors are among the most recalcitrant childhood cancers, and scientists have long sought ways to understand what drives their resilience and makes them impervious to treatment. Now researchers have uncovered a molecular chain of events that interferes with a key mechanism that regulates cell behavior and controls tumor formation.